Mei Du
Impact in
- Biochemistry top 1%
- Phytochemicals and Antioxidant Activities
- Antioxidant Activity and Oxidative Stress
- Ophthalmology top 1%
- Retinal Diseases and Treatments
Papers in
-
- Retinal Diseases and Treatments 15
- Glaucoma and retinal disorders 4
- Co-authors
- Timothy J. LyonsMingyuan WuArpita BasuNancy M. BettsChristopher E. AstonMisti J. LeyvaGraham R. FlemingSong Zhang
- Journals
- Investigative Ophthalmology & Visual Science (7 papers)Diabetologia (5 papers)The FASEB Journal (2 papers)Molecular and Cellular Biology (1 paper)Acta Pharmaceutica Sinica B (1 paper)
- Partner nations
- United StatesChinaUnited Kingdom
In The Last Decade
Mei Du
55 papers receiving 2.4k citations
Hit Papers
Peers
Comparison fields: 5 of 122
- Biochemistry 445
- Ophthalmology 383
- Neurology 191
- Biological Psychiatry 50
- Clinical Biochemistry 120
Countries citing papers authored by Mei Du
This map shows the geographic impact of Mei Du's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mei Du with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mei Du more than expected).
Fields of papers citing papers by Mei Du
This network shows the impact of papers produced by Mei Du. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mei Du. The network helps show where Mei Du may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Mei Du, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 2 | |
| 2 | 2022 | 3 | |
| 3 | 2022 | 69 | |
| 4 | 2021 | 12 | |
| 5 | 2021 | 2 | |
| 6 | The cGAS–STING signaling in cardiovascular and metabolic diseases: Future novel target option for pharmacotherapy Hit paper breakdown → | 2021 | 208 |
| 7 | 2020 | 4 | |
| 8 | 2020 | 1 | |
| 9 | 2019 | 10 | |
| 10 | 2018 | 7 | |
| 11 | 2017 | 143 | |
| 12 | 2016 | 100 | |
| 13 | 2016 | 18 | |
| 14 | 2015 | 95 | |
| 15 | 2013 | 70 | |
| 16 | Berberine Acts As A Novel Autophagy Blocker To Protect Human müLler Cell From 4-hne Induced Cell Death | 2012 | 1 |
| 17 | Acceleration Of Retinopathy By Intravitreal Injection Of Modified Low Density Lipoproteins In-STZ Diabetic Mice | 2011 | 1 |
| 18 | 2Tb/s (20×107 Gb/s) RZ-DQPSK Straight-Line Transmission over 1005 km of SSMF without Raman Amplification | 2008 | 1 |
| 19 | Hybrid CWDM Amplifier Shared by Multiple TDM PONs | 2007 | 11 |
| 20 | 2005 | 28 |
About Mei Du
Mei Du is a scholar working on Ophthalmology, Clinical Biochemistry, Biochemistry, Cellular and Molecular Neuroscience and Obstetrics and Gynecology, having authored 58 papers that have together received 2.5k indexed citations. Recurring topics across this work include Retinal Diseases and Treatments (15 papers), Optical Network Technologies (8 papers), Advanced Photonic Communication Systems (7 papers), Neuroscience and Neuropharmacology Research (5 papers), Retinal Development and Disorders (5 papers), Glaucoma and retinal disorders (4 papers), Retinoids in leukemia and cellular processes (4 papers) and Semiconductor Lasers and Optical Devices (4 papers). The work is most often cited by research in Biochemistry (445 citations), Ophthalmology (383 citations), Neurology (191 citations), Biological Psychiatry (50 citations) and Clinical Biochemistry (120 citations). Mei Du has collaborated with scholars based in United States, China and United Kingdom. Frequent co-authors include Timothy J. Lyons, Mingyuan Wu, Arpita Basu, Nancy M. Betts, Christopher E. Aston, Misti J. Leyva, Graham R. Fleming, Song Zhang, Vasanthi Jayaraman and Hua Yan. Their work appears in journals such as Investigative Ophthalmology & Visual Science, Diabetologia, The FASEB Journal, Molecular and Cellular Biology and Acta Pharmaceutica Sinica B.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.